1223281

Signature Formulations, LLC — FEI 3011368010

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 22, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
181021 CFR 211.160(a)Lab controls established, including changes
188321 CFR 211.165(a)Testing and release for distribution
191221 CFR 211.166(a)Written program not followed
438921 CFR 211.198(a)Procedures to be written and followed
900121 CFR 211.22(a)Lack of quality control unit